1. Home
  2. CCM vs PRPH Comparison

CCM vs PRPH Comparison

Compare CCM & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concord Medical Services Holdings Limited

CCM

Concord Medical Services Holdings Limited

N/A

Current Price

$3.74

Market Cap

23.8M

Sector

Health Care

ML Signal

N/A

Logo ProPhase Labs Inc. (DE)

PRPH

ProPhase Labs Inc. (DE)

HOLD

Current Price

$0.14

Market Cap

21.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCM
PRPH
Founded
1997
1989
Country
China
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8M
21.9M
IPO Year
2009
1997

Fundamental Metrics

Financial Performance
Metric
CCM
PRPH
Price
$3.74
$0.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0K
2.8M
Earning Date
09-26-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$51,056,841.00
$5,055,000.00
Revenue This Year
N/A
$221.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$0.13
52 Week High
$10.77
$0.93

Technical Indicators

Market Signals
Indicator
CCM
PRPH
Relative Strength Index (RSI) 33.78 24.55
Support Level $3.71 $0.16
Resistance Level $4.00 $0.22
Average True Range (ATR) 0.21 0.04
MACD -0.03 -0.00
Stochastic Oscillator 10.68 3.34

Price Performance

Historical Comparison
CCM
PRPH

About CCM Concord Medical Services Holdings Limited

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Share on Social Networks: